Shanghai Kinetic Medical Co., Ltd (SHE:300326)
China flag China · Delayed Price · Currency is CNY
6.48
+0.03 (0.47%)
Nov 13, 2026, 3:04 PM CST

Shanghai Kinetic Medical Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
717.08946.1962.74933.631,1461,258
Other Revenue
16.9716.9721.7822.6319.7710.44
734.04963.06984.52956.261,1661,269
Revenue Growth
-28.19%-2.18%2.96%-17.99%-8.08%19.50%
Cost of Revenue
283.54487.17505.43466.09425.97490.52
Gross Profit
450.51475.9479.09490.17740.07778.06
Selling, General & Admin
278.27352.18348.72353.05436.31406.76
Research & Development
45.4851.4143.359.3461.469.77
Other Operating Expenses
11.216.755.566.9710.449.67
Operating Expenses
342.41415.96399.97410.4527.81497.7
Operating Income
108.159.9379.1279.78212.26280.36
Interest Expense
-0.91-7.47-6.67-6.56-14.12-22.66
Interest & Investment Income
90.6331.158.1746.4716.5627.8
Currency Exchange Gain (Loss)
-1.66-1.66-0.530.48-2.331.12
Other Non Operating Income (Expenses)
-1.43-3.27-3.37-4.26-4.17-2.76
EBT Excluding Unusual Items
194.7478.6876.73115.9208.2283.86
Impairment of Goodwill
-----197.99-149.26
Gain (Loss) on Sale of Investments
39.0656.75-195.071.19-28.935.25
Gain (Loss) on Sale of Assets
1.080.26-0.1-0.370.211.6
Asset Writedown
12.5-0.38-2.91-0.58-2.01-0.14
Other Unusual Items
23.6210.1710.9917.4418.2344.93
Pretax Income
270.99145.48-110.37133.57-2.26216.31
Income Tax Expense
11.9913.86-14.156.9821.6941.31
Earnings From Continuing Operations
259131.62-96.22126.6-23.95175
Minority Interest in Earnings
9.883.27-9.35-14.062.67-13.22
Net Income
268.88134.89-105.57112.54-21.28161.78
Net Income to Common
268.88134.89-105.57112.54-21.28161.78
Net Income Growth
------
Shares Outstanding (Basic)
717717717717719722
Shares Outstanding (Diluted)
717717717717719722
Shares Change
0.04%-0.01%0.05%-0.31%-0.40%-0.16%
EPS (Basic)
0.370.19-0.150.16-0.030.22
EPS (Diluted)
0.370.19-0.150.16-0.030.22
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
208.69122.8874.91220.47195.3328.94
Free Cash Flow Per Share
0.290.170.100.310.270.46
Dividend Per Share
0.1000.100-0.060-0.050
Dividend Growth
-----0%
Gross Margin
61.37%49.41%48.66%51.26%63.47%61.33%
Operating Margin
14.73%6.22%8.04%8.34%18.20%22.10%
Profit Margin
36.63%14.01%-10.72%11.77%-1.82%12.75%
Free Cash Flow Margin
28.43%12.76%7.61%23.06%16.75%25.93%
EBITDA
142.38109.31148.63145.6273.16337.18
EBITDA Margin
19.40%11.35%15.10%15.23%23.43%26.58%
D&A For EBITDA
34.2849.3869.5265.8360.956.81
EBIT
108.159.9379.1279.78212.26280.36
EBIT Margin
14.73%6.22%8.04%8.34%18.20%22.10%
Effective Tax Rate
4.42%9.53%-5.22%-19.10%
Revenue as Reported
734.04963.06984.52956.261,1661,269